Evidence map›Paper›PMID 29751289›Full record

ArticleNeurobiology of aging2018

Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Pilar M Ferraro, Charles Jester, Christopher A Olm, Katerina Placek, Federica Agosta, Lauren Elman, Leo McCluskey, David J Irwin, John A Detre, Massimo Filippi and 2 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. European journal of radiology open · 2022
    Article
  9. Article
  10. Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Pilar M FerraroDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA; Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Charles JesterDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA.
Christopher A OlmDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA; Department of Radiology, Penn Image Computing and Science Laboratory, Philadelphia, PA, USA.
Katerina PlacekDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA.
Federica AgostaNeuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Lauren ElmanPenn Comprehensive ALS Center, University of Pennsylvania, Philadelphia, PA, USA.
Leo McCluskeyPenn Comprehensive ALS Center, University of Pennsylvania, Philadelphia, PA, USA.
David J IrwinDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA.
John A DetreDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA; Department of Radiology, Penn Image Computing and Science Laboratory, Philadelphia, PA, USA.
Massimo FilippiNeuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Murray GrossmanDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA.
Corey T McMillanDepartment of Neurology, Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA. Electronic address: mcmillac@pennmedicine.upenn.edu.
Penn Center for AIDS Research · USVita-Salute San Raffaele University · ITUniversity of Pennsylvania · US

Funding

Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DETRE, JOHN A · 1991 to 2020
$35.1M
WORKSHOP ON ADVANCES IN MUSCULOSKELETAL MRIP41RR002305 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI LICHT, DANIEL JACQUES · 1985 to 2011
$14.7M
Identification of Endophenotypes in the Behavioral-Variant of Frontotemporal DemeK23NS088341 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI IRWIN, DAVID JOHN · 2014 to 2018
$836k
Multimodal Biomarkers in Frontotemporal Lobar DegenerationK01AG043503 · NIA · UNIVERSITY OF PENNSYLVANIA · PI MCMILLAN, COREY T · 2013 to 2017
$642k
NCRR NIH HHS P41 RR002305NIA NIH HHS K01 AG043503NIA NIH HHS P01 AG017586NIA NIH HHS P30 AG010124NINDS NIH HHS K23 NS088341
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) and the behavioral variant of frontotemporal dementia (bvFTD) commonly share the presence of transactive response DNA-binding protein 43 (TDP-43) inclusions. Structural magnetic resonance imaging studies demonstrated evidence for TDP-43 pathology spread, but while structural imaging usually reveals overt neuronal loss, perfusion imaging may detect more subtle neural activity alterations. We evaluated perfusion as an early marker for incipient pathology-associated brain alterations in TDP-43 proteinopathies. Cortical thickness (CT) and perfusion measurements were obtained in ALS (N = 18), pathologically and/or genetically confirmed bvFTD-TDP (N = 12), and healthy controls (N = 33). bvFTD showed reduced frontotemporal CT, hypoperfusion encompassing orbitofrontal and temporal cortices, and hyperperfusion in motor and occipital regions. ALS did not show reduced CT, but exhibited hypoperfusion in motor and temporal regions, and hyperperfusion in frontal and occipital cortices. Frontotemporal hypoperfusion and reduced CT correlated with cognitive and behavioral impairments as investigated using Mini-Mental State Examination and Philadelphia Brief Assessment of Cognition in bvFTD, and hypoperfusion in motor regions correlated with motor disability as measured by the ALS Functional Rating Scale-Revised in ALS. Hypoperfusion marked early pathologically involved regions, while hyperperfusion characterized regions of late pathological involvement. Distinct perfusion patterns may provide early markers of pathology distribution in TDP-43 proteinopathies.

Indexed as

Cerebrovascular CirculationAgedAmyotrophic Lateral SclerosisBehaviorBiomarkersCerebral CortexCognitionFemaleFrontotemporal DementiaHumansMagnetic Resonance ImagingMaleMiddle AgedNeuroimagingNeuropsychological TestsPsychomotor PerformanceBiomarkersAmyotrophic lateral sclerosisFrontotemporal dementiaMagnetic resonance imagingPathologyPerfusionTDP-43

Identifiers

PMID29751289
PMCPMC5993674
OpenAlexW2802597158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.